Schonfeld Strategic Advisors »

Monopar Therapeutics shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $214k 2.3k 92.59

More positions owned by Schonfeld Strategic Advisors

Ishares Tr Core S&p500 Etf (IVV)
Micron Technology (MU)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Msci Brazil Etf (EWZ)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Amazon (AMZN)
Broadcom (AVGO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vale S A Sponsored Ads (VALE)
Petroleo Brasileiro S A Sponsored Adr (PBR)

View all positions for Schonfeld Strategic Advisors

Top funds holding Monopar Therapeutics

Henderson Group
Jupiter Topco
RA Capital Management
BlackRock
Deerfield Management Company
Saturn V Capital Management
Siren
ADAR1 Capital Management
Polar Capital Holdings
Vanguard Capital Management
Adage Capital Partners GP
TCG Crossover Management
Wellington Management Company
OrbiMed Advisors
Candriam Luxembourg S.C.A.

View all funds holding Monopar Therapeutics